Return to homepagePandemic Pact

to respond to the COVID-19 pandemic by developing a SARS-CoV-2 vaccine evaluated through Phase 1 clinical testing

Grant number: INV-016076

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $4,019,427

  • Funder

    Gates Foundation

  • Principal Investigator

    N/A

  • Research Location

    India

  • Lead Research Institution

    Biological E. Limited

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A